Navigation Links
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Date:5/30/2008

COLLEGEVILLE, Pa., May 30 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the INTORACT (INvestigation of TORISEL and Avastin Combination Therapy) study, a worldwide randomized, open-label, phase 3b study comparing TORISEL(R) (temsirolimus) plus Avastin(R) (bevacizumab) versus Avastin plus interferon-alfa for first-line treatment of patients with advanced renal cell carcinoma (RCC). Wyeth Research is conducting the INTORACT study with the support and assistance of Roche and Genentech.

"Several therapies have been introduced in the past few years that have led to improvements in the way we treat advanced kidney cancer," says Joseph S. Camardo, M.D., Senior Vice President, Global Medical Affairs, Wyeth Pharmaceuticals. "In the INTORACT study, we hope to learn more about whether combining TORISEL with other agents in the first-line setting may further improve outcomes for patients with this devastating disease."

The primary end point of the INTORACT study is independently assessed progression-free survival (PFS) of patients in all risk groups. Secondary end points include safety, investigator-assessed PFS, independently assessed objective response rate (complete response plus partial response) and overall survival.

A treatment regimen combining the mTOR (mammalian target of rapamycin) inhibitor TORISEL with the vascular endothelial growth factor (VEGF) inhibitor Avastin was shown in a phase 1/2 trial of patients with stage IV renal cancer to have an acceptable safety profile and supported further investigation in a phase 3 study.

"We hope to learn whether a regimen that combines the angiogenesis inhibition of bevacizumab with the mTOR inhibition of
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
2. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
3. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
4. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
5. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
9. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
10. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Calif. , Aug. 31, 2015  QT Vascular Ltd., ... Vascular", and together with its subsidiaries, the "Group"), ... and distribution of advanced therapeutic solutions for the ... the final results of the below-the-knee ("BTK") cohort ... ("BAR") which were presented on August 15, 2015 ...
(Date:8/31/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of diseases of the central nervous system ... submission has passed review by the US Food and ... 1 clinical trial in patients with metastatic colon cancer ... 31 December 2015. Bionomics, CEO & Managing ...
(Date:8/31/2015)... Wash. , Aug. 31, 2015   ... the leading developer, manufacturer and marketer of proprietary ... and cryopreservation freeze media and ... management app for smart shippers ... customer TiGenix NV, an advanced biopharmaceutical company focused ...
Breaking Medicine Technology:Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... WARREN, N.J., March 30, 2011 MonoSol Rx, ... delivery company specializing in proprietary pharmaceutical film products, ... drug (IND) meeting with the U.S. Food and ... Sodium Oral Soluble Film (OSF) under a 505(b)(2) ...
... SHELTON, Conn., March 30, 2011 Cara Therapeutics, Inc. ... Pharm.D., to the position of Chief Medical Officer.  In ... development of Cara,s lead drug candidate, CR845, a novel, ... 2 development for treatment of post-operative pain. ...
Cached Medicine Technology:MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film 2MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film 3Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer 2Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer 3
(Date:8/31/2015)... ... August 31, 2015 , ... ... collaboration with Bright Pink® to raise money and awareness for breast and ovarian ... each Hot Pink Sassy incandescent Mood-lite sold to Bright Pink® to encourage households, ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... leading nonprofit authority on the use of health IT to create efficiencies in ... conference, WEDI-Con 2015 . Taking place at the Hyatt Regency Reston in ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s big news for ZendyHealth , a ... , Consumer driven health plans (CDHPs) are a growing phenomenon, and ZendyHealth has ... to the company, and another to answer customers’ questions directly. , John Young, CEO ...
(Date:8/31/2015)... ... ... It’s a lot like coming home. Life-long Fox Valley resident James Holbrook has ... on the job, he’s run into residents of the retirement community who he’s known ... living in such a wonderful place,” he said. GreenFields, which is sponsored by Friendship ...
(Date:8/31/2015)... ... 2015 , ... Juvent Sports ( http://www.juvent.com ) just announced the addition of ... finding joint pain relief after using their revolutionary Micro-Impact Platform™ . Wilander, winner ... said, “For the first time in over 20 years I am joint pain free. ...
Breaking Medicine News(10 mins):Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3
... Alliance With Veterinary News Network, MODESTO, Calif., ... hospital captive audience digital signage solutions and systems,integration, ... of the,most comprehensive client education systems in the ... with emebaVet, bringing interesting,and accurate pet health information ...
... president and chief,executive officer, Hoffmann-La Roche Inc., told ... Rotary Club of Atlanta luncheon that the threat,of ... those,anticipated with traditional emergency preparedness plans., "While ... potential,disasters such as floods or tornadoes," according to ...
... Feb. 4 In the first study to directly ... women indicated overall satisfaction with the vaginal ring, researchers ... a publication of the American College of Obstetricians and ... prescription birth control pills, these products became available in ...
... cardiologists to coaches, NATICK, Mass., Feb. 4 ... announced the public debut of an educational,initiative called ... disparities,in cardiovascular care for the underserved patient populations ... said it is collaborating,on the Close the Gap ...
... Company Founder, Chairman and CEO Also Points Out Fundamental ... Undermine Proposed Plans to Achieve ... MedeFile,International, Inc. (OTC Bulletin Board: MDFI), a company specializing ... Presidential hopefuls for their nearly unanimous support for,the adoption ...
... and 8, listeners can, call toll-free 1-800-636-1713 or visit ... Hospital,s mission of fighting pediatric ... other catastrophic childhood diseases, MEMPHIS, Tenn., Feb. 4 ... the leading Spanish-language radio,broadcaster in the United States, joins ...
Cached Medicine News:Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 2Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 3Health News:CEO Addresses Georgia Business Leaders About Developing Pandemic and Business Continuity Plans 2Health News:CEO Addresses Georgia Business Leaders About Developing Pandemic and Business Continuity Plans 3Health News:Ringing endorsement: Women prefer contraceptive ring over patch 2Health News:Boston Scientific Launches Educational Initiative to Address Disparities in Cardiovascular Care 2Health News:Boston Scientific Launches Educational Initiative to Address Disparities in Cardiovascular Care 3Health News:Boston Scientific Launches Educational Initiative to Address Disparities in Cardiovascular Care 4Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 2Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 3Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 4Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 5Health News:Hispanic Radio Listeners Nationwide to Support Life-Saving Efforts Against Childhood Cancer 2
... 1-step, hand-held, point-of-care device for the qualitative detection ... The TOX/See device can detect up to ... 3 to 8 minutes and requires only a ... individually packaged to maximize convenience and ease of ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
Medicine Products: